Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 1
2005 2
2006 1
2007 1
2009 1
2010 2
2012 4
2014 2
2015 2
2016 3
2017 1
2018 5
2019 1
2020 5
2021 7
2022 3
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Anxiety and Fear of Breast Cancer Patients During and After the COVID-19 Era.
Vanni G, Materazzo M, Pellicciaro M, Caspi J, Portarena I, Tacconi F, Noce A, Marsella VE, Granai AV, Pistolese CA, Buonomo OC. Vanni G, et al. Among authors: portarena i. Anticancer Res. 2023 Jul;43(7):3255-3263. doi: 10.21873/anticanres.16500. Anticancer Res. 2023. PMID: 37351959
Surgical Treatments for Ductal Carcinoma In Situ (DCIS) in Elderly Patients.
Buonomo OC, Pellicciaro M, Materazzo M, Berardi S, Gigliotti PE, Caspi J, Meucci R, Perretta T, Portarena I, Dauri M, Pistolese CA, Vanni G. Buonomo OC, et al. Among authors: portarena i. Anticancer Res. 2023 Apr;43(4):1555-1562. doi: 10.21873/anticanres.16305. Anticancer Res. 2023. PMID: 36974780
Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and Trastuzumab.
Chiocchi M, Cerocchi M, Di Tosto F, Rosenfeld R, Pasqualetto M, Vanni G, De Stasio V, Pugliese L, Di Donna C, Idone G, Muscoli S, Portarena I, Roselli M, Garaci F, Floris R. Chiocchi M, et al. Among authors: portarena i. J Pers Med. 2023 Jan 22;13(2):199. doi: 10.3390/jpm13020199. J Pers Med. 2023. PMID: 36836433 Free PMC article.
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies.
Melaiu O, Vanni G, Portarena I, Pistolese CA, Anemona L, Pomella S, Bei R, Buonomo OC, Roselli M, Mauriello A, Barillari G. Melaiu O, et al. Among authors: portarena i. Int J Mol Sci. 2023 Feb 6;24(4):3226. doi: 10.3390/ijms24043226. Int J Mol Sci. 2023. PMID: 36834641 Free PMC article. Review.
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Modi S, et al. N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35665782 Free PMC article. Clinical Trial.
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature.
Botticelli A, Fabbri A, Roberto M, Alesini D, Cirillo A, D'Auria G, Krasniqi E, Marrucci E, Muratore M, Pantano F, Pizzuti L, Portarena I, Rossi R, Scagnoli S, Marchetti P. Botticelli A, et al. Among authors: portarena i. Front Oncol. 2022 Feb 9;12:797157. doi: 10.3389/fonc.2022.797157. eCollection 2022. Front Oncol. 2022. PMID: 35223478 Free PMC article.
Impact of COVID-19 Pandemic on Surgical Breast Cancer Patients Undergoing Neoadjuvant Therapy: A Multicentric Study.
Vanni G, Pellicciaro M, Combi F, Papi S, Materazzo M, Segattini S, Rizza S, Chiocchi M, Perretta T, Meucci R, Portarena I, Pistolese CA, Ielpo B, Campanelli M, Lisi G, Chiaravalloti A, Tazzioli G, Buonomo OC. Vanni G, et al. Among authors: portarena i. Anticancer Res. 2021 Sep;41(9):4535-4542. doi: 10.21873/anticanres.15265. Anticancer Res. 2021. PMID: 34475080
51 results